Benzinga | Sep 29, 2021 07:09AM EDT

Citigroup Upgrades Eli Lilly to Buy, Raises Price Target to $265

Citigroup analyst Andrew Baum upgrades Eli Lilly (NYSE:LLY) from Neutral to Buy and raises the price target from $210 to $265.